Boston Scientific Financial Statements
Boston Scientific Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Boston Scientific Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 8,050.0 | 8,357.0 | 7,821.0 |
| Gross Profit ($ mil.) | 5,581.0 | 6,015.0 | 5,614.0 |
| Operating Income ($ mil.) | (1,563.0) | 1.0 | (3,100.0) |
| Total Net Income ($ mil.) | (2,036.0) | (495.0) | (3,577.0) |
| Diluted EPS (Net Income) | (1.36) | (0.33) | (2.81) |
Boston Scientific Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 2,025.0 | 2,074.0 | 2,010.0 |
| Gross Profit ($ mil.) | 1,396.0 | 1,444.0 | 1,403.0 |
| Operating Income ($ mil.) | 341.0 | 272.0 | 5.0 |
| Total Net Income ($ mil.) | 200.0 | 158.0 | (13.0) |
| Diluted EPS (Net Income) | 0.13 | 0.10 | (0.01) |
Boston Scientific Stock Quote & Chart
11/06/09 16:01:01 EST •
NYSE •
8.08
•
 +0.0300
•
+0.3727 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Boston Scientific Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.50 | 2.38 | 7.00 |
| Price/Earnings Ratio | (5.24) | 27.86 | 25.45 |
| Price/Book Ratio | 0.89 | 2.78 | 6.74 |
| Price/Cash Flow Ratio | 8.82 | 12.80 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Boston Scientific Financial Ratios
Boston Scientific Competitive Intelligence
| Johnson & Johnson | Medtronic | St. Jude Medical | |
|---|---|---|---|
| Annual Sales ($ mil.) | 63,747.0 | 14,599.0 | 4,363.3 |
| Employees | 118,700 | 41,000 | 14,000 |
| Market Cap ($ mil.) | 165,490.8 | 42,523.4 | 12,109.7 |
Competitive Landscape
